|
Report Date : |
25.02.2013 |
IDENTIFICATION DETAILS
|
Name : |
RECKITT BENCKISER INDIA LIMITED |
|
|
|
|
Formerly Known
As : |
RECKITT AND COLMAN OF INDIA LIMITED |
|
|
|
|
Registered
Office : |
227, Okhla
Industrial Estate, Phase – III, |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as
on) : |
31.03.2012 |
|
|
|
|
Date of
Incorporation : |
05.07.1951 |
|
|
|
|
Com. Reg. No.: |
55-127062 |
|
|
|
|
Capital
Investment / Paid-up Capital : |
Rs.258.725 Millions |
|
|
|
|
CIN No.: [Company Identification
No.] |
U74999DL1951PLC127062 |
|
|
|
|
TAN No.: [Tax Deduction &
Collection Account No.] |
RTKR01561A |
|
|
|
|
PAN No.: |
AABCR2655Q |
|
|
|
|
Legal Form : |
A Closely Held Public Limited Liability Company |
|
|
|
|
Line of Business
: |
Manufacturing and Marketing of Drugs and Medicines, Bulk
Drugs, Formulations, Denture Products, Food Products, Laundry Products,
Household Products and Aromatic Chemicals. |
|
|
|
|
No. of Employees
: |
Not Available |
RATING & COMMENTS
|
MIRA’s Rating : |
A (59) |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
Maximum Credit Limit : |
USD 2400000 |
|
|
|
|
Status : |
Good |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is a well established company having good track record. The
company has changed its date of filing annual return with the government
department. As per the latest information, the company performance seems to be
high. Financially, the company seems to be strong. Liquidity position of the
company is good. Fundamental appears to be healthy. Trade relations are reported to be fair. Business is active. Payments
are reported to be regular and as per commitment. The company can be considered for normal business dealings at usual
trade terms and condition. |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – June 30, 2012
|
Country Name |
Previous Rating (31.03.2012) |
Current Rating (30.06.2012) |
|
|
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
INDIAN ECONOMIC OVERVIEW
|
Source
: CIA |
RBI DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available RBI Defaulters’ list.
EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of
31-03-2012.
LOCATIONS
|
Registered Office : |
227, Okhla
Industrial Estate, Phase – III, |
|
Tel. No.: |
91-11-41609300 |
|
Fax No.: |
91-11-26323617 |
|
E-Mail : |
surrender-sharma@reckittbenckister.com rajeshk.jha@reckittbenckiser.com
prasad.neginhal@reckittbenckiser.com
|
|
E-Mail : |
|
|
|
|
|
Corporate Office : |
Enkay Centre, 2nd Floor, Vanijya Nikunj, Udyog Vihar,
Phase V, Gurgaon -122016, |
|
Tel. No.: |
91-124-2398200/2398209 |
|
Fax No.: |
91-124-2398230/2398231/2398232 |
|
|
|
|
Factory 1 : |
25, Ho Chi Minh Sarani, Behala, Kolkata - 700 061, West |
|
Tel. No.: |
91-33-2493 4079 / 4717 |
|
Fax No.: |
91-33-2493 3529 |
|
|
|
|
Factory 2 : |
20/1, |
|
Tel. No.: |
91-33-2479 8361 / 8362 |
|
|
|
|
Factory 3 : |
P. O. Kalla, |
|
Tel. No.: |
91-341-2202521 / 2204683 |
|
Fax No.: |
91-341-2209788 |
|
|
|
|
Factory 4 : |
61-62, Hootagalli Estate, |
|
Tel. No.: |
91-821-2402509 /
2402520 |
|
Fax No.: |
91-821-2402758 |
|
|
|
|
Factory 5 : |
Plot No. 176, SIPCOT Hosur Industrial Area, Hosur - 635
126, |
|
Tel. No.: |
91-4344-276661 / 276490 |
|
Fax No.: |
91-4344-276662 / 277205 |
|
|
|
|
Factory 6 : |
B-4/10, |
|
Tel. No.: |
91-11-23272121 |
|
Fax No.: |
91-11-23281662 |
|
|
|
|
Factory 7 : |
Mahalaxmi Chambers, 29, |
|
Tel. No.: |
91-80-25584614 |
|
Fax No.: |
91-80-25584738 |
|
|
|
|
Factory 8 : |
107-111, Nirman Kendra, 1st Floor, Dr. E. Mosses Road, Near Famous Studio, Mahalaxmi, Mumbai – 400 011, Maharashtra, India |
|
Tel. No.: |
91-22-24965840 |
|
Fax No.: |
91-22-24980801 |
|
|
|
|
Factory 9 : |
41, |
|
Tel. No.: |
91-33-22886850 |
|
Fax No.: |
91-33-22888085 |
|
|
|
|
Factory 10: |
Plot No.48, Institutional Area, Sector 32, Gurgaon –
122001, |
|
Tel. No.: |
91-124-4028000 / 3319000 |
|
Fax No.: |
91-124-4340110 |
DIRECTORS
AS ON 09.08.2012
|
Name : |
Mr. Chandra Mohan Shethi |
|
Designation : |
Managing Director |
|
Address : |
302 B Court Greens, Laburnum Condominium Complex, Sushant Lok – 1,
Gurgaon – 122002, |
|
Date of Birth/Age : |
08.03.1949 |
|
Date of Appointment : |
15.11.2012 |
|
DIN No.: |
00319297 |
Other Directorship:
|
S.No. |
CIN/LLPIN |
Name
of the Company/ LLP |
Current
designation of the Director/ Designated Partner |
Date
of appointment at current designation |
Original
date of appointment |
Date
of cessation |
Company/
LLP Status |
Defaulting
status |
|
1 |
U24239MH1997PTC111897 |
RECKITT PIRAMAL
PRIVATE LIMITED |
Director |
21/01/2002 |
21/01/2002 |
- |
Active |
NO |
|
2 |
U74999DL1951PLC127062 |
RECKITT
BENCKISER ( |
Whole-time
director |
15/11/2012 |
21/01/2002 |
- |
Active |
NO |
|
3 |
U25199TN1963PLC004982 |
TTK PROTECTIVE
DEVICES LIMITED |
Director
appointed in casual vacancy |
15/11/2010 |
15/11/2010 |
09/11/2012 |
Active |
NO |
|
4 |
U24232TN1994PLC048002 |
SSL-TTK LIMITED |
Director |
03/10/2011 |
15/11/2010 |
- |
Active |
NO |
|
5 |
U65993HR2011PTC042069 |
Reckitt
Benckiser Investments India Private Limited |
Director |
11/02/2011 |
11/02/2011 |
- |
Amalgamated |
NO |
|
6 |
U24231HR1980PLC044172 |
RECKITT
BENCKISER HEALTHCARE INDIA LIMITED |
Director |
15/11/2012 |
11/04/2011 |
- |
Active |
NO |
|
7 |
U24240HR2011PTC043190 |
Halite Personal
Care India Private Limited |
Director |
15/06/2011 |
15/06/2011 |
29/05/2012 |
Active |
NO |
|
Name : |
Mr. Jose Joaquin Gonzalez |
|
Designation : |
Director appointed in casual vacancy |
|
Address : |
Bernat Disclot, 18 Casa 08190, Sant Cugat, |
|
Date of Birth/Age : |
01.08.1955 |
|
Date of Appointment : |
17.12.2008 |
|
DIN No.: |
02466459 |
Other Directorship:
|
S.No. |
CIN/LLPIN |
Name
of the Company/ LLP |
Current
designation of the Director/ Designated Partner |
Date
of appointment at current designation |
Original
date of appointment |
Date
of cessation |
Company/
LLP Status |
Defaulting
status |
|
1 |
U74999DL1951PLC127062 |
RECKITT
BENCKISER ( |
Director
appointed in casual vacancy |
17/12/2008 |
17/12/2008 |
- |
Active |
NO |
|
2 |
U24231HR1980PLC044172 |
RECKITT
BENCKISER HEALTHCARE INDIA LIMITED |
Director |
21/09/2011 |
11/04/2011 |
15/11/2012 |
Active |
NO |
|
Name : |
Mr. Rajesh Kumar Jha |
|
Designation : |
Whole – time director |
|
Address : |
C – 3, 3154, Vassant Kunj, |
|
Date of Birth/Age : |
20.06.1968 |
|
Date of Appointment : |
02.01.2012 |
|
DIN No.: |
02695721 |
Other Directorship:
|
S.No. |
CIN/LLPIN |
Name
of the Company/ LLP |
Current
designation of the Director/ Designated Partner |
Date
of appointment at current designation |
Original
date of appointment |
Date
of cessation |
Company/
LLP Status |
Defaulting
status |
|
1 |
U24239MH1997PTC111897 |
RECKITT PIRAMAL
PRIVATE LIMITED |
Director |
27/05/2010 |
10/08/2009 |
- |
Active |
NO |
|
2 |
U65993HR2011PTC042069 |
Reckitt
Benckiser Investments India Private Limited |
Additional
director |
28/03/2011 |
28/03/2011 |
- |
Amalgamated |
NO |
|
3 |
U24240HR2011PTC043190 |
Halite Personal
Care India Private Limited |
Additional
director |
11/08/2011 |
11/08/2011 |
29/05/2012 |
Active |
NO |
|
4 |
U24231HR1980PLC044172 |
RECKITT
BENCKISER HEALTHCARE INDIA LIMITED |
Alternate
director |
16/08/2011 |
16/08/2011 |
- |
Active |
NO |
|
5 |
U24232TN1994PLC048002 |
SSL-TTK LIMITED |
Director |
03/10/2011 |
03/10/2011 |
- |
Active |
NO |
|
6 |
U74999DL1951PLC127062 |
RECKITT
BENCKISER ( |
Whole-time
director |
02/01/2012 |
02/01/2012 |
- |
Active |
NO |
|
Name : |
Ms. Ariadna Granena Aracil |
|
Designation : |
Alternate director |
|
Address : |
Calle Carme Karr, 14 Bajo 4 Bracelona 08034, |
|
Date of Birth/Age : |
23.06.1974 |
|
Date of Appointment : |
26.04.2010 |
|
DIN No.: |
02773538 |
Other Directorship:
|
S.No. |
CIN/LLPIN |
Name
of the Company/ LLP |
Current
designation of the Director/ Designated Partner |
Date
of appointment at current designation |
Original
date of appointment |
Date
of cessation |
Company/
LLP Status |
Defaulting
status |
|
1 |
U74999DL1951PLC127062 |
RECKITT
BENCKISER ( |
Alternate
director |
26/04/2010 |
17/12/2009 |
- |
Active
|
|
|
Name : |
Mr. Parag Agarwal |
|
Designation : |
Whole – time director |
|
Address : |
Apartment IB, Tower TG -6, Orchid Garden, Sun City, Sector – 54,
Gurgaon – 122002, Haryana, India |
|
Date of Birth/Age : |
19.02.1966 |
|
Date of Appointment : |
26.04.2010 |
|
DIN No.: |
2954487 |
Other Directorship:
|
S.No. |
CIN/LLPIN |
Name
of the Company/ LLP |
Current
designation of the Director/ Designated Partner |
Date
of appointment at current designation |
Original
date of appointment |
Date
of cessation |
Company/
LLP Status |
Defaulting
status |
|
1 |
U74999DL1951PLC127062 |
RECKITT
BENCKISER ( |
Whole-time
director |
26/04/2010 |
03/03/2010 |
- |
Active |
NO |
|
2 |
U65993HR2011PTC042069 |
Reckitt
Benckiser Investments India Private Limited |
Director |
11/02/2011 |
11/02/2011 |
- |
Amalgamated |
NO |
|
3 |
U24231HR1980PLC044172 |
RECKITT
BENCKISER HEALTHCARE INDIA LIMITED |
Director |
21/09/2011 |
11/04/2011 |
- |
Active |
NO |
|
4 |
U24240HR2011PTC043190 |
Halite Personal
Care India Private Limited |
Director |
15/06/2011 |
15/06/2011 |
29/05/2012 |
Active |
NO |
|
5 |
U24232TN1994PLC048002 |
SSL-TTK LIMITED |
Director |
03/10/2011 |
03/10/2011 |
- |
Active |
NO |
|
Name : |
Ms. Marry Elizabeth Dohery |
|
Designation : |
Director |
|
Address : |
Waylett Barn, High Street, Clavering Essex, C.B 1148W, |
|
Date of Birth/Age : |
24.10.1957 |
|
Date of Appointment : |
10.05.2011 |
|
DIN No.: |
03463922 |
Other Directorship:
|
S.No. |
CIN/LLPIN |
Name
of the Company/ LLP |
Current
designation of the Director/ Designated Partner |
Date
of appointment at current designation |
Original
date of appointment |
Date
of cessation |
Company/
LLP Status |
Defaulting
status |
|
1 |
U74999DL1951PLC127062 |
RECKITT
BENCKISER ( |
Director |
10/05/2011 |
07/03/2011 |
- |
Active |
NO |
|
2 |
U24231HR1980PLC044172 |
RECKITT
BENCKISER HEALTHCARE INDIA LIMITED |
Director |
21/09/2011 |
11/04/2011 |
- |
Active |
NO |
|
Name : |
Mr. Ramchandran Natarajan |
|
Designation : |
Whole – time director |
|
Address : |
Flat C, First FLOOR, 15/8 Third |
|
Date of Birth/Age : |
06.04.1958 |
|
Date of Appointment : |
09.08.2012 |
|
DIN No.: |
05195809 |
Other Directorship:
|
S.No. |
CIN/LLPIN |
Name
of the Company/ LLP |
Current
designation of the Director/ Designated Partner |
Date
of appointment at current designation |
Original
date of appointment |
Date
of cessation |
Company/
LLP Status |
Defaulting
status |
|
1 |
U74999DL1951PLC127062 |
RECKITT
BENCKISER ( |
Whole-time
director |
09/08/2012 |
04/04/2012 |
- |
Active |
NO |
|
2 |
U24240HR2011PTC043190 |
Halite Personal
Care India Private Limited |
Additional
director |
23/05/2012 |
23/05/2012 |
29/05/2012 |
Active |
NO |
|
Name : |
Mr. Srinivasrao Nandigam |
|
Designation : |
Director |
|
Address : |
CI-301, Uniworld city, DLF Phase IV, Gurgeon – 122002, |
|
Date of Birth/Age : |
24.04.1969 |
|
Date of Appointment : |
01.08.2012 |
|
DIN No.: |
02410352 |
Other Directorship:
|
S.No. |
CIN/LLPIN |
Name
of the Company/ LLP |
Current
designation of the Director/ Designated Partner |
Date
of appointment at current designation |
Original
date of appointment |
Date
of cessation |
Company/
LLP Status |
Defaulting
status |
|
1 |
U74999DL1951PLC127062 |
RECKITT
BENCKISER ( |
Director |
01/08/2011 |
17/12/2008 |
05/01/2012 |
Active |
NO |
|
2 |
U24231HR1980PLC044172 |
RECKITT
BENCKISER HEALTHCARE INDIA LIMITED |
Director |
21/09/2011 |
11/04/2011 |
05/01/2012 |
Active |
NO |
|
3 |
U24232TN1994PLC048002 |
SSL-TTK LIMITED |
Alternate
director |
24/06/2011 |
24/06/2011 |
- |
Active |
NO |
|
Name : |
Mr. Roopak Sushil Taneja |
|
Designation : |
Director |
|
Address : |
C/OP Reckitt Benckiser, P. O. Box No. 61344, |
|
Date of Birth/Age : |
24.01.1967 |
|
Date of Appointment : |
10.05.2011 |
|
DIN No.: |
02889984 |
Other Directorship:
|
S.No. |
CIN/LLPIN |
Name
of the Company/ LLP |
Current
designation of the Director/ Designated Partner |
Date
of appointment at current designation |
Original
date of appointment |
Date
of cessation |
Company/
LLP Status |
Defaulting
status |
|
1 |
U74999DL1951PLC127062 |
RECKITT
BENCKISER ( |
Director |
10/05/2011 |
03/03/2010 |
03/08/2012 |
Active |
NO |
|
2 |
U24231HR1980PLC044172 |
RECKITT
BENCKISER HEALTHCARE INDIA LIMITED |
Director |
21/09/2011 |
11/04/2011 |
15/11/2012 |
Active |
NO |
|
Name : |
Mr. Alfered Kurt Caspers |
|
Designation : |
Director |
|
Address : |
Winbar, |
|
Date of Birth/Age : |
20.03.1961 |
|
Date of Appointment : |
19.04.2002 |
|
DIN No.: |
00545442 |
Other Directorship:
|
S.No. |
CIN/LLPIN |
Name
of the Company/ LLP |
Current
designation of the Director/ Designated Partner |
Date
of appointment at current designation |
Original
date of appointment |
Date
of cessation |
Company/
LLP Status |
Defaulting
status |
|
1 |
U74999DL1951PLC127062 |
RECKITT
BENCKISER ( |
Director |
19/04/2002 |
19/04/2002 |
- |
Active |
NO |
|
2 |
U25199TN1963PLC004982 |
TTK PROTECTIVE
DEVICES LIMITED |
Director
appointed in casual vacancy |
15/11/2010 |
15/11/2010 |
21/04/2011 |
Active |
NO |
|
3 |
U24232TN1994PLC048002 |
SSL-TTK LIMITED |
Director
appointed in casual vacancy |
15/11/2010 |
15/11/2010 |
21/04/2011 |
Active |
NO |
|
4 |
U24231HR1980PLC044172 |
RECKITT
BENCKISER HEALTHCARE INDIA LIMITED |
Director |
21/09/2011 |
11/04/2011 |
- |
Active |
NO |
KEY EXECUTIVES
|
Name : |
Mr. Manoj Singh Birsht |
|
Designation : |
Secretary |
|
Address : |
20B, JANTA Flats, Vasant Enclave, |
|
Date of Birth/Age : |
06.01.1988 |
|
Date of Appointment : |
04.04.2012 |
|
PAN No.: |
ALTPB3904E |
|
|
|
|
Name : |
Mr. Vishal Mehan |
|
Designation : |
Secretary |
|
Address : |
144, 2nd Floor, AGCR Enclave, Near |
|
Date of Birth/Age : |
21.08.1979 |
|
Date of Appointment : |
25.06.2010 |
|
PAN No.: |
AAIVP0847N |
MAJOR SHAREHOLDERS
AS ON 09.08.2012
|
Names of Shareholders |
No. of Shares |
|
Reckitt Banckiser PLC, U.K |
10725120 |
|
Reckitt Benckiser PLC, U.K |
6060601 |
|
|
2393185 |
|
Chandar Mohan Shethi |
1 |
|
Manish Dawar |
1 |
|
Sarrita William |
1 |
|
Ajay Thukral |
1 |
|
R and C Nomimee Limited (Beneficial Owner Reckitt Benckiser PLC), U.K |
1 |
|
|
6693556 |
|
TOTAL
|
25872467 |
AS ON 09.08.2012
|
Equity Shares Break
Up |
Percentage of
Holding |
|
Foreign holdings( Foreign institutional
investor(s), Foreign companie(s) Foreign financial institution(s),
Non-resident Indian(s) or Overseas Corporate bodies or Others |
100.00 |
|
TOTAL |
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Manufacturing and marketing of Drugs and Medicines, Bulk
Drugs, Formulations, Denture Products, Food Products, Laundry Products,
Household Products and Aromatic Chemicals. |
||||||||||||||
|
|
|
||||||||||||||
|
Products : |
|
GENERAL INFORMATION
|
No. of Employees : |
Not Available |
|
|
|
|
Bankers : |
·
Standard Chartered Bank, 4, |
|
|
|
|
Facilities : |
- |
|
|
|
|
Banking
Relations : |
-- |
|
|
|
|
Auditors : |
|
|
Name : |
Price WaterHouse Chartered Accountant |
|
Address : |
Price WatereHouse, Building 8, 7th and 8th floor
tower B, |
|
PAN No.: |
AAEFP3641G |
|
|
|
|
Holding Company : |
Reckitt Benckiser plc, UK CIN No - U24239MH1997PTC111897 |
|
|
|
|
Subsidiaries : |
Reckitt Piramal Private Limited |
|
|
|
|
Fellow Subsidiaries : |
·
·
Reckitt Benckiser Corporate Services ·
Reckitt & Colman (Overseas) ·
Reckitt Benckiser Healthcare ( ·
Reckitt Benckiser ( ·
Reckitt Benckiser (Lanka) Limited. ·
Reckitt Benckiser ·
Reckitt
Benckiser Pakistan Limited ·
Reckitt Benckiser N.V., Netherland ·
PT. Reckitt Benckiser ·
Benckiser Produktions GmbH ·
Reckitt Benckiser ( ·
Reckitt Benckiser ·
Reckitt Benckiser Household Products ( ·
Reckitt Benckiser Arabia FZE, UAE. ·
Reckitt Benckiser ·
Reckitt Benckiser Nigeria Limited. ·
Reckitt Benckiser Australia Pty Limited ·
Reckitt Benckiser ( ·
Reckitt Benckiser ·
Reckitt Benckiser ( ·
Reckitt Benckiser Production ( ·
Reckitt Benckiser Investment India Private
Limited ·
Reckitt Benckiser Holding GmbH and Company, KG ·
Reckitt Benckiser Hong Kong Limited ·
Reckitt Benckiser Healthcare India Limited
(formerly known as Paras Pharmaceuticals Limited) ·
Reckitt Benckiser LLC ·
Reckitt Benckiser Healthcare International
Limited ·
Reckitt Benckiser Healthcare Manufacturing ( ·
Reckitt Benckiser Brasil Limited A |
CAPITAL STRUCTURE
AS ON 31.03.2012
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
35000000 |
Equity Shares |
Rs.10/- each |
Rs.35.000 Millions |
|
|
|
|
|
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
25872467 |
Equity Shares |
Rs.10/- each |
Rs.
258.725 Millions |
|
|
|
|
|
FINANCIAL DATA
[all figures are
in Rupees Millions]
ABRIDGED BALANCE
SHEET
|
SOURCES OF FUNDS |
31.03.2012 (15 Months) |
31.12.2010 (12 Months) |
31.12.2009 (12 Months) |
|
|
SHAREHOLDERS FUNDS |
|
|
|
|
|
1] Share Capital |
258.725 |
262.796 |
262.796 |
|
|
2] Share Application Money |
0.000 |
0.000 |
0.000 |
|
|
3] Reserves & Surplus |
6362.452 |
1437.815 |
1085.086 |
|
|
4] (Accumulated Losses) |
0.000 |
0.000 |
0.000 |
|
|
NETWORTH |
6621.177 |
1700.611 |
1347.882 |
|
|
LOAN FUNDS |
|
|
|
|
|
1] Secured Loans |
0.000 |
0.000 |
0.000 |
|
|
2] Unsecured Loans |
0.000 |
0.000 |
0.000 |
|
|
TOTAL BORROWING |
0.000 |
0.000 |
0.000 |
|
|
DEFERRED TAX LIABILITIES |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
6621.177 |
1700.611 |
1347.882 |
|
|
|
|
|
|
|
|
APPLICATION OF FUNDS |
|
|
|
|
|
|
|
|
|
|
|
FIXED ASSETS [Net Block] |
1979.657 |
1677.912 |
1094.373 |
|
|
Capital work-in-progress |
273.426 |
284.240 |
457.566 |
|
|
|
|
|
|
|
|
INVESTMENT |
0.000 |
0.000 |
5.000 |
|
|
DEFERREX TAX ASSETS |
191.983 |
208.173 |
104.118 |
|
|
|
|
|
|
|
|
CURRENT ASSETS, LOANS & ADVANCES |
|
|
|
|
|
|
Inventories |
3654.114
|
1554.936
|
1554.936
|
|
|
Sundry Debtors |
807.891
|
343.519
|
343.519
|
|
|
Cash & Bank Balances |
5222.622
|
1334.486
|
1334.486
|
|
|
Other Current Assets |
30.746
|
11.123
|
11.123
|
|
|
Loans & Advances |
981.045
|
318.778
|
318.778
|
|
Total
Current Assets |
10696.418
|
4749.270 |
3562.842 |
|
|
Less : CURRENT
LIABILITIES & PROVISIONS |
|
|
|
|
|
|
Sundry Creditors |
5274.154
|
4028.938 |
324.622
|
|
|
Other Current Liabilities |
525.599
|
78.483 |
2556.611
|
|
|
Provisions |
720.554
|
1111.563 |
994.784
|
|
Total
Current Liabilities |
6520.307
|
5218.984 |
3876.017 |
|
|
Net Current Assets |
4176.111
|
(469.714) |
(313.175) |
|
|
|
|
|
|
|
|
MISCELLANEOUS EXPENSES |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
6621.177 |
1700.611 |
1347.882 |
|
PROFIT & LOSS
ACCOUNT
|
|
PARTICULARS |
31.03.2012 (15 Months) |
31.12.2010 (12 Months) |
31.03.2009 (12 Months) |
|
|
|
SALES |
|
|
|
|
|
|
|
Income |
34934.983 |
21657.802 |
17901.185 |
|
|
|
Other Income |
1229.517 |
361.377 |
224.532 |
|
|
|
TOTAL (A) |
36164.500 |
22019.179 |
18125.717 |
|
|
|
|
|
|
|
|
Less |
EXPENSES |
|
|
|
|
|
|
|
Manufacturing service costs |
3413.829 |
2333.144 |
7634.360 |
|
|
|
Employee related expenses |
1377.419 |
1024.958 |
896.056 |
|
|
|
Administrative selling other expenses |
5282.182 |
4337.473 |
6033.466 |
|
|
|
Consumption material change inventories |
18935.259 |
9864.575 |
0.000 |
|
|
|
TOTAL (B) |
29008.689 |
17560.150 |
14563.882 |
|
|
|
|
|
|
|
|
Less |
PROFIT
/ (LOSS) BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B) (C) |
7155.811 |
4459.029 |
14740.583 |
|
|
|
|
|
|
|
|
|
Less/ Add |
DEPRECIATION/
AMORTISATION (F) |
390.199 |
382.862 |
176.701 |
|
|
|
|
|
|
|
|
|
|
PROFIT / (LOSS)
BEFORE TAX (E-F) (G) |
6765.612 |
4076.167 |
3385.134 |
|
|
|
|
|
|
|
|
|
Less |
TAX (H) |
1382.589 |
690.462 |
465.511 |
|
|
|
|
|
|
|
|
|
|
PROFIT / (LOSS)
AFTER TAX (G-H) (I) |
5383.023 |
3385.705 |
2919.623 |
|
|
|
|
|
|
|
|
|
Add |
PREVIOUS
YEARS’ BALANCE BROUGHT FORWARD |
14.531 |
0.373 |
1.481 |
|
|
|
|
|
|
|
|
|
Less |
APPROPRIATIONS |
|
|
|
|
|
|
|
Transfer to General Reserve |
63.764 |
3371.547 |
2920.731 |
|
|
BALANCE CARRIED
TO THE B/S |
5333.790 |
14.531 |
0.373 |
|
|
|
|
|
|
|
|
|
|
EARNINGS IN
FOREIGN CURRENCY |
|
|
|
|
|
|
|
Export Earnings |
N.A |
25.443 |
17.927 |
|
|
TOTAL EARNINGS |
N.A |
25.443 |
17.927 |
|
|
|
|
|
|
|
|
|
|
IMPORTS |
|
|
|
|
|
|
|
Raw Materials |
N.A |
384.411 |
154.246 |
|
|
|
Capital Goods |
N.A |
1.816 |
21.503 |
|
|
TOTAL IMPORTS |
N.A |
386.227 |
175.749 |
|
|
|
|
|
|
|
|
|
|
Earnings Per
Share (Rs.) |
205.19 |
128.83 |
95.86 |
|
KEY RATIOS
|
PARTICULARS |
|
31.03.2012 (15 Months) |
31.12.2010 (12 Months) |
31.03.2009 (12 Months) |
|
PAT / Total Income |
(%) |
14.88
|
17.46 |
16.11 |
|
|
|
|
|
|
|
Net Profit Margin (PBT/Sales) |
(%) |
19.37
|
18.82 |
2.15 |
|
|
|
|
|
|
|
Return on Total Assets (PBT/Total Assets} |
(%) |
187.36
|
157.68 |
137.58 |
|
|
|
|
|
|
|
Return on Investment (ROI) (PBT/Networth) |
|
1.02
|
2.40 |
0.29 |
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
1.64
|
0.90 |
0.92 |
LOCAL AGENCY FURTHER INFORMATION
|
Sr. No. |
Check List by Info Agents |
Available in
Report (Yes / No) |
|
1] |
Year of Establishment |
Yes |
|
2] |
Locality of the firm |
Yes |
|
3] |
Constitutions of the firm |
Yes |
|
4] |
Premises details |
No |
|
5] |
Type of Business |
Yes |
|
6] |
Line of Business |
Yes |
|
7] |
Promoter's background |
Yes |
|
8] |
No. of employees |
No |
|
9] |
Name of person contacted |
Yes |
|
10] |
Designation of contact
person |
Yes |
|
11] |
Turnover of firm for last
three years |
Yes |
|
12] |
Profitability for last
three years |
Yes |
|
13] |
Reasons for variation
<> 20% |
----- |
|
14] |
Estimation for coming
financial year |
No |
|
15] |
Capital in the business |
Yes |
|
16] |
Details of sister
concerns |
Yes |
|
17] |
Major suppliers |
No |
|
18] |
Major customers |
No |
|
19] |
Payments terms |
No |
|
20] |
Export / Import details
(if applicable) |
No |
|
21] |
Market information |
----- |
|
22] |
Litigations that the firm
/ promoter involved in |
----- |
|
23] |
Banking Details |
Yes |
|
24] |
Banking facility details |
No |
|
25] |
Conduct of the banking
account |
----- |
|
26] |
Buyer visit details |
----- |
|
27] |
Financials, if provided |
Yes |
|
28] |
Incorporation details, if
applicable |
Yes |
|
29] |
Last accounts filed at
ROC |
Yes |
|
30] |
Major Shareholders, if
available |
Yes |
|
31] |
Date of Birth of
Proprietor/Partner/Director, if available |
Yes |
|
32] |
PAN of
Proprietor/Partner/Director, if available |
No |
|
33] |
Voter ID No of Proprietor/Partner/Director,
if available |
No |
|
34] |
External Agency Rating,
if available |
No |
The following is the search result, derived from data covering period
as per list
|
ENTITY |
PERSON |
COMPETENT
AUTHORITY |
REGULAREITY
CHARGES |
REGULARITY
ACTION(S) / DATE OF ORDER |
FURTHER
DEVELOPMENTS |
|
RECKITT
BENCKISER (INDIA) LIMITED |
|
BSE |
Compliance with clause 21(3)(a) of the SEBI(SAST) regulations |
Delisted due to compliance with clause 21(3)(A)From 19 – May – 2003 |
|
|
RECKITT
BENCKISER (INDIA) LIMITED |
|
EPFO |
Establishments defaulted with EPFO including provident fund, pension and
EDLI contribution, administration charges and penal damages of Rs.1.675
millions |
19-Nov-2007 Among Other action, names of defaulters put on the EPFO Website 31.03.2005 |
|
|
RECKITT
BENCKISER (INDIA) LIMITED |
|
NSE |
Not available |
Delisted From 12.05.2003 25.02.2004 |
|
FORM 8
|
Corporate
identity number of the company |
U74999DL1951PLC127062 |
|
Name of the
company |
RECKITT BENCKISER
( |
|
Address of the
registered office or of the principal place of business in |
227 Okhla
Industrial Estate, Phase Iii, |
|
This form is for |
Modification of
charge Creation of
charge |
|
Type of charge |
Others |
|
Particular of
charge holder |
Director of Industries
Himachal Pradesh, through Member
Secretary, SWCA, Parwanoo Himachal
Pradesh-173220, |
|
Nature of
instrument creating charge |
Agreement of
Hypothecation for Central Capital Investment Subsidy dated 19th August 2008. |
|
Date of
instrument Creating the charge |
19/08/2008
|
|
Amount secured by
the charge |
Rs.3.000 Millions |
|
Brief of the
principal terms an conditions and extent and operation of the charge |
Rate of interest Nil Terms of repayment Nil Margin Nil Extent and
operation of the charge The charge would
operate and will be valid for a period of 5 years in order to ensure that the
conditions prescribed under the Central Capital Investment Subsidy Scheme,
2003 are complied with. |
|
Short particulars
of the property charged (Including location of the property) |
All machinery and
equipments belonging to the Company and lying at its unit situated at
Parwanoo, District Solan, Himachal Pradesh. |
FIXED ASSETS
·
Vehicles
and Computer
WEB DETAILS
PRESS RELEASE
RECKITT BENCKISER
ANNOUNCES LATAM OTC COLLABORATION WITH BRISTOL-MYERS SQUIBB
Slough, England – 12 February, 2012 – Reckitt Benckiser Group PLC (“RB”) (LSE: RBL) today announced that it has signed a three year collaboration agreement with Bristol-Myers Squibb (“BMS”) for a number of market-leading over-the-counter (“OTC”) consumer health care brands in Brazil, Mexico and certain other parts of Latin America (collectively “BMS Assets”), with an option to purchase at the end of the three year period. The key brands included under the agreement are:
|
Brazil |
Mexico |
|
Naldecon – leading cough and
cold brand |
Tempra – No.1 in adult and
pediatric pain relief |
|
Luftal – No.1 in anti-flatulence |
Picot – No.1 in antacids |
|
Dermodex – leading nappy rash brand |
Graneodin-B – No.1 in sore throat |
Under this collaboration, RB will licence the brands from BMS, who will
continue to manufacture them for three years.
Rakesh
Kapoor, Reckitt Benckiser Chief Executive Officer, said,
“This
transaction creates a material consumer health care platform, infrastructure
and distribution network for RB in both Brazil and Mexico. As such it is an
important step in building our consumer health care presence in Latin American
emerging markets.
“These
market-leading brands have strong margins and I firmly believe they have
extremely good growth potential. They fit into our existing OTC categories of
pain relief, sore throat, cough and cold, anti-acid, and dermatological and
will benefit from RB’s consumer marketing and innovation capabilities, and our
significant levels of brand equity investment.”
Under the terms of the agreement RB will initially pay BMS $482 million to
enter into the arrangement which also includes personnel, supply contracts and
an option to acquire legal title to the related intellectual property at the
end of the collaboration period, based on business performance. The transaction
will be accounted for as a business combination and the Directors are in the
process of revaluing the assets and liabilities acquired to fair value,
including the value of any acquired intangible assets. Under the terms of a
separate supply agreement BMS will be RB’s supplier of the products during the
collaboration period.
BMS Assets had unaudited reported net revenue for the year ended 31 December
2012 of $102 million.
The Company expect the transaction to be EPS* accretive from 2014 under IFRS.
Excluding the amortization we expect it to be immediately EPS* accretive(1).
The collaboration will come into effect following regulatory approvals,
including anti-trust approvals in the relevant jurisdictions. This is expected
to be completed in Q2 2013.
*Adjusted results exclude the impact of exceptional items
(1) Under IFRS a fair value of the collaboration agreement is
required to be calculated and amortized over the collaboration period.
RECKITT EXPECTS INDIA TO BE LARGEST MKT IN 3-5YRS
Consumer goods major Reckitt Benckiser said it expects the Indian
operations to become its biggest market globally in terms of revenue in the
next 3-5 years.
"My aim and vision is that India should become the single biggest
market in the next 3-5 years for Reckitt Benckiser in revenue," Reckitt
Benckiser South East Asia Senior Vice- President Chander Mohan Sethi told PTI.
The company has globally identified and named 16 'power markets' for
future growth and India is at present fourth in the list of top five markets,
he added,
"I know that it is not going to be easy to compete with markets
like the US, but we will do it on the back of innovation and investment on
building our brands," Sethi said.
He said India is one of the fastest growing markets in the world for the
company.
"India is critical for global growth and is in the top block for
investment and focus," he said without sharing any financial detail.
Reckitt Benckiser had recorded a net revenue of 2,357 million pound
during January-March quarter this year.
The top focus markets for the company include the US, the UK, Germany,
France, India, Brazil, Russia, South Africa, China and Australia.
Commenting on the strategy for the future growth in the Indian market,
Sethi said: "We will focus on areas like health, hygiene and home, and
invest in innovation... Health is clearly the focus area that is why we
acquired Paras."
Last year, Reckitt Benckiser had completed acquisition of Paras
Pharmaceutical's over-the-counter brands, including Moov pain relief ointment,
Krack heel care lotion and D'Cold cold remedy for Rs 32600.000 millions, along
with its personal care business with brands such as Set Wet and Zatak, and hair
lotion brand Livon.
Following this deal, Reckitt Benckiser, the maker of Dettol, Lysol,
Bang, Vanish, and Veet, directly entered the personal care segments such as
deodorants, haircare products, anti-ageing creams and over-the-counter healthcare
products.
However, Reckitt Benckiser had sold part of the personal care business
of Paras Pharma to Marico earlier this year.
When asked if Reckitt Benckiser was looking for more acquisitions, Sethi
said: "We are always on a look out, but it is a matter of finding the
right opportunity and time."
RECKITT BENCKISER AIMS TO LAUNCH
19 POWER BRANDS WORLD OVER
DECEMBER 15, 2012
In an interview to CNBC-TV18’s Forbes India Show, Rakesh Kapoor, chief executive officer, Reckitt Benckiser explains the progress the company has made so far and how his journey has been till date. Kapoor started the company Reckitt Colman in India 25 years ago. Reckitt Benckiser is more commonly found in everybody’s homes as different brands like Dettol, Strepsils, Harpic, Cherry Blossom, which is now "Cherry" Charlie, Durex, Vanish, Airwick.
Q: You are having more and more Indians heading global companies, but when you joined Reckitt Colman, 25 years ago, did you think you will rise up to this?
A: You don’t think about your career in so many steps. You think about your career one step at a time and you can only do that provided, you do a great job at what you have been dealt with. So, I never thought about 10 steps in my life. I just thought of about the job I had at that time and tried to do it the best way I could. That took me to the next job and so on and so forth.
Q: You took over from Bart Becht, a man who is credited with really pushing Reckitt Benckiser into the big league with a number of acquisitions and that was the DNA. You took over Boots and Adams in which you are pretty closely involved. But is that time over? Is it consolidation time? Or are you still scouting out?
A: Although, we have some pretty interesting acquisitions over the last many years, but the whole story of Reckitt Benckiser is one of organic growth. If you strip out all the acquisitions the last decade has produced a growth rate on a compounded basis of 7 percent per annum. That puts us at the top of the league in our industry. So, I think acquisitions have played a role, but Reckitt continues to be an organic growth story first and foremost.
We bought some brands both in India with Paras and in North America with Schiff. All of these play a role, but by and large the story still will be an organic growth story.
Q: Your site says, by 2020 you would like to atleast double revenues and you would like to see your power brands driving this. In India other companies have tried, the concept of power brand, but haven’t quite succeeded. How do you define a power brand and can you have a set of power brands that will work across geographies, in a developing market as well as in developed markets?
A: Earlier this year, just a few months after I had taken over as CEO, we decided that we needed to reshape the strategy of this company to be successful in the next decade. I just talked about how successful we have been in the last decade. We were one of the best-performing stories in our industry and clearly it is important for us to think about how we want to be successful in the next decade. Apart from that- thinking through the strategy was to really go back to the basics and the basics of who we wanted to be as a company, what we wanted to stand for and the purpose of this company .
Our purpose was having healthier lives and happier homes and I would like to explain the whole thing about power brands in the context of healthier lives and happier homes. That’s the reason why we created three planks or three platforms for our portfolio- health, hygiene and home. Now they also are connected. They seem like three discrete platforms, but to my mind, they are all connected. They are connected because you do need good hygiene to have good health and a healthier home is a happier home. We can unite the whole portfolio of our power brands within the umbrella of health, hygiene and home. We have 19 power brands around the world. So, there are some brands that provide hygiene; Dettol is a great example of that. You can wash your hands and keep them hygienically clean. You can keep your surfaces clean and hygienically clean.
Q: However, these 19 power brands are equally powerful
all over the world. Or do you decide that in a particular country you will
focus on one brand and another country, you’ll focus on some other brand?
A: Our ultimate goal is to have 19 power brands in all the countries.
Now it is true that at this stage we do not have 19 power brands in every
country, certainly not in India, the United States or in the United Kingdom
(UK). And that offers us a tremendous opportunity to expand our power brand
portfolio over time. That is something we call white space opportunities.
Q: When you say expand, do you mean expanding your existing 19 brands in all geographies or expand into other power brands as well?
A: Our first objective, which is called the organic story, is to take these 19 power brands and make them successful everywhere in the world. For example, in India in the last couple of years, we have launched Mucinex. We have launched Gaviscon and ofcourse Vanish a couple of years before that. So, we do take our power brands and take them into different parts of the world. We have just launched Vanish in test markets in China. So, these are things that we want to do. We believe 19 power brands can be important and successful in every market that we operate in the world.
RECKITT BENCKISER TO SELL STAKE IN TTK-LIG TO TTK GROUP
CHENNAI, OCT. 2:
The Reckitt Benckiser group has finally agreed to sell its stake in condom maker TTK-LIG Ltd to the TTK group.
During the hearing of an appeal in the Supreme Court on Monday, the UK-based New Bridge Holdings BV, subsidiary of Reckitt Benckiser Plc, agreed to sell its 49.8 per cent stake in TTK-LIG that makes Durex and Kohinoor brands of condoms, to TTK.
RBI approval pending
Confirming this development, R. Jawahar Lal, Partner at PRA Law Officers, Advisors of New Bridge Holdings, told Business Line, that it will take a couple of weeks for the formalities to be completed.
“The outer time-frame for the deal is October 31,” he said. However, he refused to reveal the deal value, as there are many formalities pending, including RBI approval.
The TTK group had moved the Supreme Court against the Madras High Court’s order appointing an administrator, replacing the board of directors of TTK-LIG.
Earlier, in its order, the Company Law Board appointed Ernst & Young to value the joint venture company, to enable either one of the parties to exit. The company has been exporting condoms under the Durex brand to the foreign partner.
Differences between Reckitt and TTK emerged in May 2011 over everything from nomination of directors to pricing and distribution strategy.
Specifically, Reckitt objected to a 35 per cent increase in the price it had to pay for condoms supplied to it by the joint venture firm TTK-LIG for the international market.
Supply issues
After that, TTK stopped supply to Reckitt. Sales to Reckitt accounted for 80 per cent of TTK-LIG’s revenues.
The joint venture was originally formed in 1963 between TTK and London International Group Plc. In 1999, LIG was acquired by SSL International Plc.
Two years ago (in 2010), in its biggest acquisition, Reckitt Benckiser acquired SSL International for $3.9 billion. By virtue of that buy, Reckitt became TTK’s joint venture partner.
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist
organization or whom notice had been received that all financial transactions
involving their assets have been blocked or convicted, found guilty or against
whom a judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No exist to suggest that subject is or was
the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or investigation
registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority
for any financial crime or under any formal investigation by a competent
government authority for any violation of anti-corruption laws or international
anti-money laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.54.43 |
|
|
1 |
Rs.83.20 |
|
Euro |
1 |
Rs.71.91 |
INFORMATION DETAILS
|
Report Prepared
by : |
HET |
SCORE & RATING EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
6 |
|
PAID-UP CAPITAL |
1~10 |
6 |
|
OPERATING SCALE |
1~10 |
7 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
7 |
|
--PROFITABILIRY |
1~10 |
7 |
|
--LIQUIDITY |
1~10 |
6 |
|
--LEVERAGE |
1~10 |
6 |
|
--RESERVES |
1~10 |
7 |
|
--CREDIT LINES |
1~10 |
7 |
|
--MARGINS |
-5~5 |
-- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
NO |
|
--AFFILIATION |
YES/NO |
YES |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
TOTAL |
|
59 |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
- |
NB |
New Business |
- |
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.